Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/24/26 17:20 | 6/24/25 | ARVN | Health | Drug | Pharmaceutical Preparations | Saik Andrew | CT | O | CFO | 4 | S | -262 | 9.45 | 0 | -28 | 193 | D | |||||||||||||||
6/18/26 16:06 | 6/17/25 | ARVN | Health | Drug | Pharmaceutical Preparations | Cacace Angela M | CT | O | Chief Sc | 5 | S | -233 | 10.14 | 0 | -23 | 183 | D | |||||||||||||||
5/22/26 16:15 | 5/21/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Teel Randy | CT | DO | P,CEO | 4 | S | -226 | 10.76 | 0 | -21 | 287 | D | |||||||||||||||
5/13/26 16:17 | 5/11/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Loomis David K | CT | O | VP,Chief | 4 | S | -47 | 10.98 | 0 | -4 | 40 | D | |||||||||||||||
5/13/26 16:16 | 5/11/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Berkowitz Noah | CT | O | Chief Me | 3 | S | -249 | 10.74 | 0 | -23 | 203 | D | |||||||||||||||
3/2/26 20:57 | 2/27/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Houston John G | CT | D | 1 | S | -466 | 13.21 | 0 | -35 | 1,122 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |